Evaluation of Medication Adherence to Influenza Treatment with Oseltamivir in Children

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022027

Enrollment

Unknown

Registered

2019-03-21

Start date

2019-04-01

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

Group1:Treated with imported oseltamivir

Group2:Treated with domestically-produced oseltamivir

Eligibility

Sex/Gender

All

Age

No minimum to 14 Years

Inclusion criteria

Inclusion criteria: Pediatric patients aged from 0 to 14 years who got influenza and were treated with oseltamivir in the outpatient or emergency department of Children's Hospital of Fudan University.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
Medication Adherence;	—

Secondary

Measure	Time frame
Efficacy;	—

Countries

China

Contacts

Public ContactZhiping Li

zplifudan@126.com+86 021-64931224

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026